Search Within

Melissa P Pulitzer

Formats
  1. Journal Article (133)
  2. Meeting Abstract (55)
  3. Research Letter (11)
  4. Review (5)
  5. Book Section (3)
  6. Conference Paper (2)
  7. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (210)
  2. Department of Medicine (134)
  3. Dermatology Service (120)
  4. Division of Subspecialty Medicine (118)
  5. Dermatology (117)
  6. Melanoma Disease Management Team (70)

More Groups

People
  1. Patricia Myskowski (60)
  2. Steven Horwitz (49)
  3. Klaus Busam (48)
  4. Alison Moskowitz (34)
  5. Shamir Geller (33)
  6. Stephen Dusza (25)

More People

Years
  1. 2025 (11)
  2. 2024 (12)
  3. 2023 (9)
  4. 2022 (15)
  5. 2021 (15)
  6. 2020 (6)

More Years

Publications
  1. Journal of the American Academy of Dermatology (27)
  2. Journal of Cutaneous Pathology (20)
  3. Blood (15)
  4. American Journal of Surgical Pathology (10)
  5. American Journal of Dermatopathology (9)
  6. Modern Pathology (9)

More Publications

Publishers
  1. Mosby Elsevier (27)
  2. Lippincott Williams & Wilkins (25)
  3. John Wiley & Sons (22)
  4. Wiley Blackwell (21)
  5. Elsevier Inc. (17)
  6. American Society of Hematology (15)

More Publishers

Results (210)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pralatrexate in relapsed/refractory HTLV-1 associated adult T-cell lymphoma/leukemia: A New York City multi-institutional experience
    Meeting Abstract

    Lunning, M. A.; Gonsky, J.; Ruan, J.; Phillips, A. A.; Pulitzer, M.; Moskowitz, A.; Querfeld, C.; Myskowski, P. L.; Noy, A.; Horwitz, S. M.
    Blood (2012)

    Fulltext@MSK | Save
  • Clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides: A single center experience from Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Li, J. Y.; Pulitzer, M.; Myskowski, P. L.; Dusza, S.; Horwitz, S. M.; Moskowitz, A.; Querfeld, C.
    Blood (2012)

    Fulltext@MSK | Save
  • Brentuximab vedotin demonstrates significant clinical activity in relapsed or refractory mycosis fungoides with variable CD30 expression
    Meeting Abstract

    Krathen, M.; Sundram, U.; Bashey, S.; Sutherland, K.; Salva, K.; Wood, G. S.; Advani, R. H.; Hoppe, R. T.; Reddy, S.; Armstrong, R.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Molecular Diagnosis of Infection-Related Cancers in Dermatopathology
    Journal Article

    Pulitzer, M.
    Seminars in Cutaneous Medicine and Surgery (2012)

    Fulltext@MSK | Save
  • Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors
    Journal Article

    Balagula, Y.; Rosen, A.; Tan, B. H.; Busam, K. J.; Pulitzer, M. P.; Motzer, R. J.; Feldman, D. R.; Konner, J. A.; Reidy-Lagunes, D.; Myskowski, P. L.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Adult T-cell leukemia/lymphoma with follicular mucinosis: An unusual histopathological finding and a commentary
    Journal Article

    Camp, B.; Horwitz, S.; Pulitzer, M. P.
    Journal of Cutaneous Pathology (2012)

    Fulltext@MSK | Save
  • Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma
    Journal Article

    Lok, B.; Khan, S.; Mutter, R.; Liu, J.; Fields, R.; Pulitzer, M.; Shi, W.; Zhang, Z.; Kraus, D.; Pfister, D.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • Combined intraepidermal neuroendocrine (Merkel cell) and squamous cell carcinoma in situ with CM2B4 negativity and p53 overexpression
    Journal Article

    Tan, B. H.; Busam, K. J.; Pulitzer, M. P.
    Journal of Cutaneous Pathology (2012)

    Fulltext@MSK | Save
  • Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma
    Journal Article

    Fields, R. C.; Busam, K. J.; Chou, J. F.; Panageas, K. S.; Pulitzer, M. P.; Allen, P. J.; Kraus, D. H.; Brady, M. S.; Coit, D. G.
    Cancer (2012)

    Fulltext@MSK | Save
  • Exploratory study of brentuximab vedotin (SGN-35), a novel monoclonal antibody-drug-conjugate against CD30, in mycosis fungoides (MF) and Sézary syndrome (SS) demonstrates clinical responses regardless of CD30 expression levels
    Meeting Abstract

    Bashey, S.; Krathen, M.; Sutherland, K.; Sundram, U.; Lingala, B.; Horwitz, S.; Hoppe, R.; Pulitzer, M.; Advani, R.; Kim, Y.
    Journal of Investigative Dermatology (2012)

    Fulltext@MSK | Save